5. Bj6rklund, A. and T. H6kfelt (Eds.). Handbook of Chemical
Neuroanatomy, Vol 4, GABA and Neuropeptides in the CNS,
Part 1. Amsterdam: Elsevier, 1985.
6. Brazeau, P., W. Vale, R. Burgus, N. Ling, M. Butcher, J.
Rivier and R. Guillemin. Hypothalamic polypeptide that inhibits
the secretion of immunoreactive pituitary growth hormone. Science 179: 77-79, 1973.
7. Brown, M. R., L. A. Fisher, P. E. Sawchenko, L. W. Swanson
and W. W. Vale. Biological effects of cysteamine: Relationship
to somatostatin depletion. Regul Pept 5: 163-179, 1983.
8. Brownstein, M. J., A. Arimura, H. Sato, A. V. Schally and J. S.
Kizer. Regional distribution of somatostatin in the rat brain.
Endocrinology 96: 1456-1461, 1975.
9. Carlsson, A. Drugs which block the storage of
5-hydroxytryptamine and related amines. In: Handbuch Exp
Pharm, vol 19, edited by V. Erspamer. Berlin: Springer, 1965,
pp. 52%592.
10. Chan-Palay, V. and S. L. Palay (Eds.). Coexistence of
Neuroactive Substances in Neurons. New York: John Wiley
and Sons, 1984.
11. Christensson-Nylander, I., F. Nyberg, U. Ragnarsson and L.
Terenius. A general procedure for analysis of proenkephalin B
derived opioid peptides. Regul Pept 11: 65-76, 1985.
12. Coons, A. A. Fluorescent antibody methods. In: General
Cytochemical Methods, edited by J. F. Danielli, New York:
Academic Press, 1958, pp. 39%422.
13. Cuello, A. C. (Ed.). Co-Transmission. London: MacMillan,
1982.
14. Dalsgaard, C.-J., S. R. Vincent, T. H6kfelt, Z. WiesenfeldHallin, L. L. Gustafsson, R. EIde and G. J. Dockray. Effects of
cysteamine on pain behaviour and on somatostatin- and substance P-like immunoreactivity in the substantia gelatinosa of
the rat. Eur J Pharmacol 104: 295-301. 1984.
15. Elde, R., T. H6kfelt, O. Johansson, M. Schultzberg, S. Efendi6
and R. Luft. Cellular localization of somatostatin. Metabolism
27: 1151-1159, 1978.
16. Finley, J. C. W., J. L. Maderdrut, L. J. Roger and P. Petrusz.
The immunocytochemical localization of somatostatincontaining neurons in the rat central nervous system. Neuroscience 6: 2173-2192, 1981.
17. Foster, G. A. and O. Johansson. Ultrastructural morphometric
analysis of somatostatin-like immunoreactive neurones in the
rat central nervous system after labelling with colloidal gold.
Brain Res 342:117-127, 1985.
18. Fried, G., L. Terenius, T. H6kfelt and M. Goldstein. Evidence
for differential localization of noradrenaline and neuropeptide Y
in neuronal storage vesicles isolated from rat vas deferens. J
Neurosci 5: 450-458, 1985.
19. Gasparovi6, I., S. Hadzovic, S. Hukovic and P. Stern. Contribution to the theory that substance P has a transmitter role in
sensitive pathway. Med Exp (Basel) 10: 303-306, 1964.
20. Gilbert, R. F. T., G. W. Bennett, C. A. Marsden and P. C.
Emson. The effects of 5-hydroxytryptamine-depleting drugs on
peptides in the ventral spinal cord. Eur J Pharmacol 76: 203- 210, 1981.
21. Goldsmith, P. C. Ultrastructural localization of some hypothalamic hormones. Fed Prac 36: 1968-1972, 1977.
22. Goldstein, A., W. Fischli, L. I. Lowney, M. Hunkapiller and L.
Hood. Porcine pituitary dynorphin: complete amino acid se- quence of the biologically active heptadecapeptide. Prac Natl
Acad Sci USA 78: 721%7223, 1981.
23. Goldstein, A., S. Tachibana, L. I. Lowney, M. Hunkapiller and
L. Hood. Dynorphin-(1-13), an extraordinarily potent opioid
peptide. Prac Natl Acad Sci USA 76: 6666-6670, 1979.
24. Graybiel, A. M. and R. P. Elde. Somatostatin-like im- munoreactivity characterizes neurons of the nucleus reticularis
thalami in the cat and monkey. J Neurosci 3: 1308-1321,
1983.
Helke, C. J. and J. H. Selsky. The effects of cysteamine and
capsaicin on somatostatin and substance P in medullary nuclei.
Peptides 4: 66%672, 1983.
